OPK (OPKO Corp) Company Short-Term Debts

OPK (OPKO Health, Inc.) - company brandmark

The current short-term liabilities chart for OPKO Health, Inc. (OPK) stands at 0.04. The business relies on a synthesis of diagnostic services and drug development, which minimizes biotech sector risks. Growth is driven by the optimization of the BioReference network and the drug Rayaldee. High barriers to entry, in the form of complex certifications and an extensive patent portfolio, make the company a key healthcare player, protecting its market positions.

OPK OPKO Health Inc Company Short-Term Debt (07/04/2022 - 10/30/2026)

Metric breakdowns and analytics for OPKO Health Corp. (OPK)

- current quotes and average value forecast:
Price Chart OPKO Health|OPK - Broker Consensus Forecast
- business market valuation indicators:
Market Capitalization OPKO Health, Inc.|OPK - Enterprise Value
- business book valuation details:
Net Assets per Single Share OPKO Health|OPK - Company Book Value|Market Cap to Net Assets Ratio opko.com|OPK - Company Assets
- debt level and financial liquidity data:
Debt to Equity OPKO Health, Inc.|OPK - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Capital OPKO Health, Inc.|OPK - Company Total Debt Obligations|Debt to Book Capitalization Ratio OPKO Health, Inc.|OPK - Long-Term Debt Volume|Company Short-Term Debt OPKO Health|Quick Liquidity opko.com
- earnings and multiples data:
OPK - Profit After Tax
Fundamental company analysis:OPK - OPKO Health
Mass-produced product of OPKO Health Corp.

The liquidity of OPKO Health, Inc. (OPK) determines the resilience of its operating model. This parameter measures the aggregate of all liabilities with a maturity horizon of up to twelve months. The metric assesses the company's ability to service current loans without compromising growth. Optimizing such payments is critical when utilizing external contractors for the production and logistics of diagnostic tests. The dynamics of short-term loan debt signal the extent of the business's dependence on borrowed capital.

Competitors of OPKO Health, Inc.

A - Company Short-Term Debt|DGX (Quest Diagnostics Inc.) - Company Short-Term Indebtedness|ILMN: Company Short-Term Debts|Exact Sciences Inc. (EXAS) - Company Short-Term Debts|Company Short-Term Debt Revvity, Inc.|Company Short-Term Debt BIO|Company Current Liabilities NNNN (Anbio)|SHC - Short-Term Debt|Company Short-Term Debt QuidelOrtho Corp QDEL|Short-Term Debt Volume CareDx (CDNA)|Maravai LifeSciences - Company Short-Term Debts|Short-Term Debt Volume fulgentgenetics.com FLGT|Standard BioTools (LAB) - Company Short-Term Debt|CTKB - Short-Term Debt Volume|Company Short-Term Debt OraSure Technologies Inc|Short-Term Debt Exagen Diagnostics XGN|Company Short-Term Debt MDxHealth SA (MDXH)|LUCD: Current Liabilities|Company Short-Term Debt Prenetics PRE|Company Short-Term Debts Insight Molecular Diagnostics, Inc. IMDX|TRIB - Company Short-Term Debt|Short-Term Debt ProPhase Labs Corp|AIMD (Ainos, Inc.) - Company Current Liabilities|codiagnostics.com - Company Short-Term Loans and Borrowings|HSCS (HeartSciences) - Company Short-Term Debts|BMRA: Company Short-Term Loans and Borrowings|Company Short-Term Debts CDIO|VRAX - Short-Term Debt|Company Short-Term Debts BJDX (Bluejay Diagnostics)|Company Short-Term Debts aspirawh.com AWH|AXDX - Company Short-Term Debt|CNTG: Company Short-Term Debt|ENZ (enzo.com) - Company Current Liabilities|FRES: Amount of Current Liabilities|GENE (Genetic Technologies Ltd) - Company Short-Term Debts|ME: Company Short-Term Loans and Borrowings|Company Current Liabilities PMD (Psychemedics Corporation)